Patents by Inventor Vic Narry Kim

Vic Narry Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8673855
    Abstract: The present invention relates to a phosphatidylinositol 3-kinases activity regulator which include the fifth zinc finger domain of FOG2 and which, more specifically, can induce cancer cells to die due to the inclusion of the fifth zinc finger domain of FOG2. Since the death of cancer cells is induced by suppressing the transfer of PI3K signals, the fifth zinc finger domain of FOG2 according to the present invention can be suitably use as a composition for the prevention and treatment of PI3K-related diseases.
    Type: Grant
    Filed: June 8, 2010
    Date of Patent: March 18, 2014
    Assignee: Seoul National University R&DB Foundation
    Inventors: Vic Narry Kim, Jung Hyun Lee
  • Publication number: 20130116185
    Abstract: The present invention relates to a phosphatidylinositol 3-kinases activity regulator which include the fifth zinc finger domain of FOG2 and which, more specifically, can induce cancer cells to die due to the inclusion of the fifth zinc finger domain of FOG2. Since the death of cancer cells is induced by suppressing the transfer of PI3K signals, the fifth zinc finger domain of FOG2 according to the present invention can be suitably use as a composition for the prevention and treatment of PI3K-related diseases.
    Type: Application
    Filed: June 8, 2010
    Publication date: May 9, 2013
    Applicant: SNU R&DB FOUNDATION
    Inventors: Vic Narry Kim, Jung Hyun Lee
  • Publication number: 20130011845
    Abstract: The present invention relates to a miRNA regulating the insulin signaling pathway, and to a method for screening a material for controlling the action of a target gene thereof, and particularly, to a method for screening a material for controlling the action of USH or FOG2, a target gene of miR-8 or miR-200 miRNA for promoting cell growth. The present inventors discovered miR-8, a conserved miRNA for regulating the body of a fruit fly by targeting u-shaped material (USH) in the fat cells of Drosophila. It was also confirmed that a target gene of miR-200, a human homologous gene of Drosophila miR-8 miRNA, is FOG2. It was found that Drosophila miR-8 and USH are also conserved in mammals, and FOG2, a human homologous gene of USH, directly binds to a regulating subunit of PI3K and functions. It was confirmed that when the expression of miR-200 is inhibited or FOG2 is expressed in a human cancer cell line, the activity of PI3K, which promotes cell growth, is decreased.
    Type: Application
    Filed: December 2, 2009
    Publication date: January 10, 2013
    Applicant: SNU R & DB Foundation
    Inventors: Vic Narry Kim, Jung Hyun Lee, Seogang Hyun, Hua Jin
  • Publication number: 20110230367
    Abstract: The present invention relates to an amphiphilic peptide capable of promoting target miRNA production and a method for regulating the production of target miRNA using the same. In detail, the amphiphilic peptide of the present invention binds strongly and specifically to hairpin-shaped target miRNA. The specific binding affinity induces the Dicer enzyme activity, therefore specifically increase the production of target miRNA. The present invention can be effectively used for regulating the amount of target miRNA produced in vivo, for the study of miRNA functions and for producing therapeutic drug for target miRNA related disease.
    Type: Application
    Filed: November 23, 2009
    Publication date: September 22, 2011
    Applicant: SNU R&DB FOUNDATION
    Inventors: Jaehoon Yu, Vic Narry Kim, Soonsil Hyun